KNSA logo

Kiniksa Pharmaceuticals (KNSA) Revenue

Annual revenue:

$423.24M+$152.98M(+56.60%)
December 31, 2024

Summary

  • As of today (May 11, 2025), KNSA annual revenue is $423.24 million, with the most recent change of +$152.98 million (+56.60%) on December 31, 2024.
  • During the last 3 years, KNSA annual revenue has risen by +$384.69 million (+998.07%).
  • KNSA annual revenue is now at all-time high.

Performance

1-year change

+56.6%

3-year change

+998.07%

5-year change

-

15-year change

-

KNSA Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

72.2%
KNSA annual revenue is higher than 72.2% of companies in Healthcare sector

Analysts estimate

$599.62M
KNSA annual revenue is currently -29.42% lower than the consensus analysts' forecast

Range

All-time high

$423.24M
KNSA annual revenue is currently at an all-time high

3-year low

$38.54M
KNSA annual revenue is currently +998.07% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
KNSA previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
KNSA next annual earnings announcement has not yet been scheduled

OtherKNSAincome statement metrics

Annual EPS

-$0.60
KNSA annual earnings per share is -$0.60

annual net income

-$43.19M
KNSA annual net profit is -$43.19 million

annual operating profit

-$45.62M
KNSA annual operating income is -$45.62 million

Annual gross profit

$362.33M
KNSA annual gross profit is $362.33 million

Quarterly revenue:

$137.78M+$15.25M(+12.44%)
March 31, 2025

Summary

  • As of today (May 11, 2025), KNSA quarterly revenue is $137.78 million, with the most recent change of +$15.25 million (+12.44%) on March 31, 2025.
  • Over the past year, KNSA quarterly revenue has increased by +$57.93 million (+72.54%).
  • KNSA quarterly revenue is now at all-time high.

Performance

3-month change

+12.44%

1-year change

+72.54%

3-year change

+328.05%

5-year change

-

KNSA Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

71.17%
KNSA quarterly revenue is higher than 71.17% of companies in Healthcare sector

Analysts estimate

$145.22M
KNSA quarterly revenue is currently -5.12% lower than the consensus analysts' forecast

Range

All-time high

$137.78M
KNSA quarterly revenue is currently at an all-time high

3-year low

$26.97M
KNSA quarterly revenue is currently +410.84% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
KNSA previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 23, 2025
KNSA next earnings announcement is scheduled for Jul 23, 2025

OtherKNSAincome statement metrics

quarterly gross profit

$76.13M
KNSA quarterly gross profit is $76.13 million

quarterly operating profit

$13.27M
KNSA quarterly operating income is $13.27 million

quarterly net income

$8.54M
KNSA quarterly net profit is $8.54 million

Quarterly EPS

$0.11
KNSA quarterly earnings per share is $0.11

TTM revenue:

$481.17M+$57.93M(+13.69%)
March 31, 2025

Summary

  • As of today (May 11, 2025), KNSA TTM revenue is $481.17 million, with the most recent change of +$57.93 million (+13.69%) on March 31, 2025.
  • Over the past year, KNSA TTM revenue has increased by +$179.39 million (+59.45%).
  • KNSA TTM revenue is now at all-time high.

Performance

3-month change

+13.69%

1-year change

+59.45%

3-year change

+580.26%

5-year change

-

KNSA TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

70.54%
KNSA TTM revenue is higher than 70.54% of companies in Healthcare sector

Analysts estimate

$517.75M
KNSA TTM revenue is currently -7.07% lower than the consensus analysts' forecast

Range

All-time high

$481.17M
KNSA TTM revenue is currently at an all-time high

3-year low

$70.73M
KNSA TTM revenue is currently +580.26% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 31, 2025
KNSA previous earnings announcement was published on Mar 31, 2025

Next quarterly earnings report date

Jul 23, 2025
KNSA next earnings announcement is scheduled for Jul 23, 2025

OtherKNSAincome statement metrics

TTM gross profit

$389.98M
KNSA TTM gross profit is $389.98 million

TTM operating profit

-$15.80M
KNSA TTM operating income is -$15.80 million

TTM net income

-$16.95M
KNSA TTM net profit is -$16.95 million

TTM EPS

-$0.25
KNSA TTM earnings per share is -$0.25

KNSA Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+56.6%+72.5%+59.5%
3 y3 years+998.1%+328.1%+580.3%
5 y5 years---

KNSA Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+998.1%at high+410.8%at high+580.3%
5 y5-yearat high+998.1%at high+1688.5%at high+6145.7%
alltimeall timeat high+998.1%at high+1688.5%at high+6145.7%

KNSA Revenue History

DateAnnualQuarterlyTTM
Mar 2025
-
$137.78M(+12.4%)
$481.17M(+13.7%)
Dec 2024
$423.24M(+56.6%)
$122.54M(+9.2%)
$423.24M(+10.2%)
Sep 2024
-
$112.21M(+3.3%)
$384.10M(+13.3%)
Jun 2024
-
$108.63M(+36.0%)
$338.93M(+12.3%)
Mar 2024
-
$79.86M(-4.2%)
$301.77M(+11.7%)
Dec 2023
$270.26M
$83.39M(+24.4%)
$270.26M(+8.6%)
Sep 2023
-
$67.05M(-6.2%)
$248.75M(-11.4%)
Jun 2023
-
$71.47M(+47.8%)
$280.84M(+18.8%)
DateAnnualQuarterlyTTM
Mar 2023
-
$48.34M(-21.9%)
$236.34M(+7.3%)
Dec 2022
$220.18M(+471.2%)
$61.88M(-37.6%)
$220.18M(+24.4%)
Sep 2022
-
$99.14M(+267.5%)
$177.04M(+96.7%)
Jun 2022
-
$26.97M(-16.2%)
$90.00M(+27.2%)
Mar 2022
-
$32.19M(+71.7%)
$70.73M(+83.5%)
Dec 2021
$38.54M
$18.75M(+55.0%)
$38.54M(+94.7%)
Sep 2021
-
$12.10M(+57.0%)
$19.80M(+157.0%)
Jun 2021
-
$7.70M
$7.70M

FAQ

  • What is Kiniksa Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual revenue year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly revenue year-on-year change?
  • What is Kiniksa Pharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals TTM revenue year-on-year change?

What is Kiniksa Pharmaceuticals annual revenue?

The current annual revenue of KNSA is $423.24M

What is the all time high annual revenue for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual revenue is $423.24M

What is Kiniksa Pharmaceuticals annual revenue year-on-year change?

Over the past year, KNSA annual revenue has changed by +$152.98M (+56.60%)

What is Kiniksa Pharmaceuticals quarterly revenue?

The current quarterly revenue of KNSA is $137.78M

What is the all time high quarterly revenue for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly revenue is $137.78M

What is Kiniksa Pharmaceuticals quarterly revenue year-on-year change?

Over the past year, KNSA quarterly revenue has changed by +$57.93M (+72.54%)

What is Kiniksa Pharmaceuticals TTM revenue?

The current TTM revenue of KNSA is $481.17M

What is the all time high TTM revenue for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high TTM revenue is $481.17M

What is Kiniksa Pharmaceuticals TTM revenue year-on-year change?

Over the past year, KNSA TTM revenue has changed by +$179.39M (+59.45%)
On this page